Commissioner Von Eschenbach: NCI Director Named Acting Head Of FDA
This article was originally published in The Tan Sheet
Executive Summary
National Cancer Institute Director Andrew von Eschenbach, MD, brings extensive scientific expertise and experience working with Congress as the head of a high-profile federal agency to the role of FDA commissioner
You may also be interested in...
A Brief But Memorable Tenure: Former US FDA Commissioner Lester Crawford Dies At 83
Crawford’s time as permanent FDA commissioner lasted less than three months and ended in scandal, but with that stint and his longer stretches as acting commissioner, he oversaw the agency through several historic moments that continue to influence the current regulatory environment.
Crawford Pleads Guilty Of Failing To Disclose Stocks In Firms FDA Regulates
Former FDA Commissioner Lester Crawford on Oct. 17 pleaded guilty in federal court to charges related to owning stocks in companies regulated by the agency
Crawford Pleads Guilty Of Failing To Disclose Stocks In Firms FDA Regulates
Former FDA Commissioner Lester Crawford on Oct. 17 pleaded guilty in federal court to charges related to owning stocks in companies regulated by the agency